前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：201702252572481905 整理番号：17A1559480

1p/19q非Co欠失未分化神経膠腫のための同時的およびアジュバント的なテモゾロミドによる治療のCATNON試験(EORTC研究26053 22054)の中間結果:第3相,無作為化,非盲検群間研究【Powered by NICT】

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

著者 (52件)：

van den Bent Martin J

(Neuro-Oncology Unit, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

Baumert Brigitta

(Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Centre (MUMC), Maastricht, Netherlands)

Baumert Brigitta

(GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands)

Baumert Brigitta

(Department of Radiation-Oncology, University of Muenster, Muenster, Germany)

Baumert Brigitta

(Paracelsus Clinic, Osnabrueck, Germany)

Erridge Sara C

(Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburgh, UK)

Vogelbaum Michael A

(Department of Neurosurgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA)

Vogelbaum Michael A

(Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA)

Nowak Anna K

(School of Medicine and Pharmacology, University of Western Australia, Crawley, WA, Australia)

Nowak Anna K

(Co-Operative Group for Neuro-Oncology, University of Sydney, Camperdown, NSW, Australia)

Nowak Anna K

(Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, Australia)

Sanson Marc

(Sorbonne Universites UPMC, University Paris VI, INSERM, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM), Hopital Pitie-Salpetriere, F-75013, Paris, France)

Brandes Alba Ariela

(Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy)

Clement Paul M

(Department of Oncology, KU Leuven, Leuven, Belgium)

Clement Paul M

(Department of General Medical Oncology, UZ Leuven, Leuven Cancer Institute, Leuven, Belgium)

Baurain Jean Francais

(Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium)

Mason Warren P

(Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada)

Wheeler Helen

(Northern Sydney Cancer Centre, North Shore Hospital, St Leonards, NSW, Australia)

Wheeler Helen

(Department of Medicine, University of Sydney, Sydney, NSW, Australia)

Chinot Olivier L

(Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France)

Gill Sanjeev

(Department of Medical Oncology, Alfred Hospital, Melbourne, VIC, Australia)

Griffin Matthew

(Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK)

Brachman David G

(Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA)

Taal Walter

(Neuro-Oncology Unit, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

Ruda Roberta

(Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy)

Weller Michael

(Department of Neurology and Brain Tumour Centre, University Hospital and University of Zurich, Zurich, Switzerland)

McBain Catherine

(Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, UK)

Reijneveld Jaap

(VUmc Cancer Centre Amsterdam, VU University Medical Centre, Amsterdam, Netherlands)

Reijneveld Jaap

(Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands)

Reijneveld Jaap

(Department of Neurology, Academic Medical Centre, Amsterdam, Netherlands)

Enting Roelien H

(Department of Neurology, UMCG, University of Groningen, Groningen, Netherlands)

Weber Damien C

(Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland)

Lesimple Thierry

(Department of Clinical Oncology, Comprehensive Cancer Center Eugene Marquis, Rennes, France)

Clenton Susan

(Weston Park Hospital, Sheffield, UK)

Gijtenbeek Anja

(Department of Neurology, Radboud University Medical Centre, Nijmegen, Netherlands)

Pascoe Sarah

(Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK)

Herrlinger Ulrich

(Division of Clinical Neuro-Oncology, Department of Neurology, University of Bonn Medical Centre, Bonn, Germany)

Hau Peter

(Wilhelm Sander-Neuro-Oncology Unit and Department of Neurology, University Hospital Regensburg, Regensburg, Germany)

Dhermain Frederic

(Radiotherapy Department, Gustave Roussy University Hospital, Villejuif, France)

van Heuvel Irene

(Neuro-Oncology Unit, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

Stupp Roger

(Department of Medical Oncology, University Hospital and University of Zurich, Zurich, Switzerland)

Aldape Ken

(Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada)

Jenkins Robert B

(Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA)

Dubbink Hendrikus Jan

(Department of Pathology, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

Dinjens Winand N M

(Department of Pathology, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

Wesseling Pieter

(Department of Pathology, VU University Medical Centre, Amsterdam, Netherlands)

Wesseling Pieter

(Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands)

Nuyens Sarah

(EORTC, Brussels, Belgium)

Golfinopoulos Vassilis

(EORTC, Brussels, Belgium)

Gorlia Thierry

(EORTC, Brussels, Belgium)

Wick Wolfgang

(Neurologische Klinik und Nationales Zentrum fuer Tumorerkrankungen Universitaetsklinik, Heidelberg, Germany)

Kros Johan M

(Department of Pathology, Brain Tumour Centre at Erasmus MC Cancer Institute, Rotterdam, Netherlands)

資料名：

Lancet (Lancet)

巻： 390 号： 10103 ページ： 1645-1653 発行年： 2017年
JST資料番号： B0673A ISSN： 0140-6736 CODEN： LANCA 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：オランダ (NLD) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM